EurekAlert! reports a team led by the Rutgers Institute for Translational Medicine and Science (including Princeton University and the New Jersey Institute of Technology) has received a National Institutes of Health grant for $29 million over five years for joining the NIH’s Clinical and Translational Science Awards Program (CTSA). The CTSA program at Rutgers University will be known as NJ ACTS: New Jersey Alliance for Clinical and Translational Science. Additional funding from the institutions will grow the program to about $45 million.
The grant will build a pipeline for new clinical investigators by funding two positions a year for five years for junior faculty or professionals finishing their post-doctoral fellowship who can move into faculty positions with two years of guaranteed support. It will fund six positions for graduate students, who will be trained in translational and clinical research.
The grant was awarded due to the strength of RITMS, the alliance between Rutgers Biomedical and Health Sciences, Princeton and NJIT, and the partnerships with community-based organizations, hospitals, community health centers, outpatient practices, data centers and health information exchanges. It reaches nearly seven million of the state’s nine million residents.Source: www.eurekalert.org